Blood Cancer Journal (Jun 2021)
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
- Ahmad Nanaa,
- David Viswanatha,
- Zhuoer Xie,
- Dragan Jevremovic,
- Phuong Nguyen,
- Mohamad E. Salama,
- Patricia Greipp,
- Kurt Bessonen,
- Naseema Gangat,
- Mrinal Patnaik,
- Animesh Pardanani,
- Hassan B. Alkhateeb,
- Mithun Shah,
- William Hogan,
- Ayalew Tefferi,
- Mark Litzow,
- Rong He,
- Aref Al-Kali
Affiliations
- Ahmad Nanaa
- Division of Hematology, Mayo Clinic
- David Viswanatha
- Division of Hematopathology, Mayo Clinic
- Zhuoer Xie
- Division of Hematology, Mayo Clinic
- Dragan Jevremovic
- Division of Hematopathology, Mayo Clinic
- Phuong Nguyen
- Division of Hematopathology, Mayo Clinic
- Mohamad E. Salama
- Division of Hematopathology, Mayo Clinic
- Patricia Greipp
- Division of Cytogenetics, Mayo Clinic
- Kurt Bessonen
- Division of Hematopathology, Mayo Clinic
- Naseema Gangat
- Division of Hematology, Mayo Clinic
- Mrinal Patnaik
- Division of Hematology, Mayo Clinic
- Animesh Pardanani
- Division of Hematology, Mayo Clinic
- Hassan B. Alkhateeb
- Division of Hematology, Mayo Clinic
- Mithun Shah
- Division of Hematology, Mayo Clinic
- William Hogan
- Division of Hematology, Mayo Clinic
- Ayalew Tefferi
- Division of Hematology, Mayo Clinic
- Mark Litzow
- Division of Hematology, Mayo Clinic
- Rong He
- Division of Hematopathology, Mayo Clinic
- Aref Al-Kali
- Division of Hematology, Mayo Clinic
- DOI
- https://doi.org/10.1038/s41408-021-00517-0
- Journal volume & issue
-
Vol. 11,
no. 6
pp. 1 – 4
Abstract
No abstracts available.
